Search Results

Displaying Results 7126-7150 of 8008 "'III'"

Nov 18, 2025, 16:00 ET Rice Acquisition Corporation 3 Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing November 21, 2025

https://ricespac.com/rac-iii. About Rice Investment Group Rice Investment Group

More news about: Rice Investment Group


Nov 18, 2025, 14:54 ET Amtrak: A Year of Records

progress on major bridge, tunnel and station projects like the Portal North Bridge, Connecticut River Bridge, East River Tunnel, and William H. Gray, III 30th Street Station in Philadelphia. Rail yard upgrades to support the new Airo fleet advanced in Seattle and along the East Coast. Station modernization

More news about: Amtrak


Nov 18, 2025, 12:47 ET AbbVie Announces U.S. FDA Approval of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide for Relapsed or Refractory Follicular Lymphoma

https://lymphoma.org/aboutlymphoma/nhl/fl/. Accessed November 2025.iii Leukemia & Lymphoma Society. 

More news about: AbbVie


Nov 18, 2025, 12:39 ET La Opulence Collection de Royal Canadian Mint regresa con monedas de platino y oro con diamantes amarillos

El anverso de ambas monedas presenta la efigie de Su Majestad el Rey Carlos III, obra del artista canadiense Steven Rosati. Estas preciosas piezas de colección se presentan en estuches de madera negra mate elaborados por el fabricante

More news about: Royal Canadian Mint (RCM)


Nov 18, 2025, 12:22 ET LA COLECCIÓN OPULENCE DE LA REAL CASADE LA MONEDADE CANADÁ REGRESA CON MONEDAS DE PLATINO Y ORO CON DIAMANTES AMARILLOS DE LA MINA DE DIAMANTES EKATI DE RENOMBRE MUNDIAL DE CANADÁ

limitados a una acuñación de solo 30 unidades. Los anversos de ambas monedas presentan la efigie de su majestad el rey Carlos III realizada por el artista canadiense Steven Rosati. Estos preciosos objetos de colección también se presentan en estuches de madera negra mate elaborados

More news about: Royal Canadian Mint (RCM)


Nov 18, 2025, 12:20 ET A COLEÇÃO OPULENCE DA ROYAL CANADIAN MINT RETORNA COM MOEDAS DE PLATINA E OURO COM DIAMANTES AMARELOS DA MUNDIALMENTE FAMOSA MINA DE DIAMANTES EKATI DO CANADÁ

são limitados a uma cunhagem de apenas 30. Os anversos de ambas as moedas apresentam a imagem de Sua Majestade, o Rei Charles III, do artista canadense Steven Rosati. Esses preciosos colecionáveis também são apresentados em caixas de madeira preta fosca criadas pela fabricante canadense

More news about: Royal Canadian Mint (RCM)


Nov 18, 2025, 12:16 ET THE ROYAL CANADIAN MINT'S OPULENZ-KOLLEKTION IST ZURÜCK MIT PLATIN- UND GOLDMÜNZEN, GESCHMÜCKT MIT GELBEN DIAMANTEN AUS KANADAS WELTBERÜHMTEM EKATI-DIAMANTENBERGWERK.

eine Auflage von nur 30 Stück begrenzt. Die Vorderseiten dieser beiden Münzen zeigen das Bildnis Seiner Majestät König Karls III. des kanadischen Künstlers Steven Rosati. Diese kostbaren Sammlerstücke werden in mattschwarzen Holzkoffern des kanadischen Herstellers Manubois präsentiert.

More news about: Royal Canadian Mint (RCM)


Nov 18, 2025, 11:06 ET European Commission Approves BRINSUPRI® (brensocatib) as the First and Only Treatment To Date Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union

decline.i, iii Unlike other respiratory diseases that are characterised by airway narrowing, bronchiectasis causes airways to permanently widen, making it harder to clear mucus and bacteria, leading to persistent inflammation and infection.i, iii A hallmark of bronchiectasis

More news about: Insmed Incorporated


Nov 18, 2025, 11:00 ET Arcadia University to Launch Men's & Women's Fencing in 2027

fencing programs, to begin competition in the fall of 2027. According to USA Fencing, Arcadia will become the 13th Division III men's fencing program (38th overall) and the 17th Division III women's fencing program (46th overall) in the NCAA.

More news about: Arcadia University


Nov 18, 2025, 09:05 ET Majority of U.S. Level III & IV NICUs in 2025 Used Prolacta's 100% Breastmilk-Based Fortifiers & Formulas to Improve Outcomes for Premature Infants

Prolacta Bioscience® is celebrating Prematurity Awareness Month with a significant milestone in neonatal care: In 2025, the majority of Level III and IV neonatal intensive care units (NICUs) in the U.S. (55%) used Prolacta's 100% breastmilk-based fortifiers and formulas, free from cow milk.1

More news about: Prolacta Bioscience


Nov 18, 2025, 09:00 ET DXCM LAWSUIT ALERT: Levi & Korsinsky Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

and G7 less reliable than their prior iterations, presenting a material health risk to users relying on those devices for accurate glucose readings; (iii) accordingly, defendants' purported enhancements to the G7, as well as the device's reliability, accuracy, and functionality, were overstated; (iv) defendants

More news about: Levi & Korsinsky, LLP


Nov 18, 2025, 09:00 ET Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 12, 2026 in Firefly Aerospace Inc. Lawsuit - FLY

for its Spacecraft Solutions offerings; (ii) Firefly had overstated the operational readiness and commercial viability of its Alpha rocket program; (iii) the foregoing, once revealed, would likely have a material negative impact on the Company; and (iv) as a result, the offering documents and defendants'

More news about: Levi & Korsinsky, LLP


Nov 18, 2025, 09:00 ET DuPont Breaks Ground on MOLYKOTE® Lubricants Manufacturing Plant in China

the Aramids Divestiture and ownership of the Equity Consideration on DuPont's balance sheet, financial condition and future results of operations; (iii) risks and costs related to the impact of the arrangement to share future eligible PFAS costs by and among DuPont, Corteva and Chemours, including the

More news about: DuPont


Nov 18, 2025, 08:00 ET Kangpu to Present Latest Study Results of epaldeudomide (KPG-818) at the 67th ASH Annual Meeting

Poster Number: 5809 Poster Category: 654. Multiple Myeloma: Pharmacologic Therapies: Poster III Presenter: Dr. Aaron Rosenberg, MD, UC Davis Comprehensive Cancer Center, California, United States

More news about: Kangpu Biopharmaceuticals


Nov 18, 2025, 08:00 ET Eisai to Present Data on Lecanemab Continued Treatment, Subcutaneous Initiation Dosing, and Real-World Experience at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference

PM PT, new analyses will be presented on benefits of continued therapy and estimated time savings over 10 years of lecanemab treatment based on Phase III clinical data (LB12, LB21). Subcutaneous Initiation Dosing: On Wednesday, Dec. 3, the late-breaking

More news about: Eisai Inc.


Nov 18, 2025, 08:00 ET Labaton Keller Sucharow LLP Announces a Proposed Class Action Settlement Involving Purchasers of the Publicly Traded Common Stock of Opendoor Technologies Inc.

fair, reasonable, and adequate; (ii) dismiss the Action with prejudice as provided in the Stipulation and Agreement of Settlement, dated June 13, 2025; (iii) approve the proposed Plan of Allocation for distribution of the proceeds of the Settlement (the "Net Settlement Fund") to Settlement Class Members;

More news about: Labaton Keller Sucharow LLP


Nov 18, 2025, 08:00 ET THE ROYAL CANADIAN MINT'S OPULENCE COLLECTION RETURNS WITH PLATINUM AND GOLD COINS FEATURING YELLOW DIAMONDS FROM CANADA'S WORLD-RENOWNED EKATI DIAMOND MINE

treasures are limited to a mintage of only 30. The obverses of both these coins feature the effigy of His Majesty King Charles III by Canadian artist Steven Rosati. These precious collectibles are also presented in matte black wood cases crafted by Canadian manufacturer Manubois.

More news about: Royal Canadian Mint


Nov 18, 2025, 08:00 ET LA COLLECTION OPULENCE DE LA MONNAIE ROYALE CANADIENNE S'ENRICHIT DE PIÈCES EN OR ET EN PLATINE ORNÉES DE DIAMANTS JAUNES, TOUS EXTRAITS DE LA MINE DE DIAMANTS CANADIENNE DE RENOMMÉE MONDIALE EKATI

30 exemplaires de ces chefs-d'œuvre fabriqués à la main. L'avers de ces deux pièces est à l'effigie de Sa Majesté le roi Charles III, selon l'artiste canadien Steven Rosati. Ces précieux articles de collection sont assortis d'un coffret en bois noir mat confectionné par le fabricant

More news about: Monnaie royale canadienne (MRC)


Nov 18, 2025, 08:00 ET Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health

Ginkgo operates and plans to operate, variations in performance across competitors, and changes in laws and regulations affecting Ginkgo's business, (iii) the ability to implement business plans, forecasts, and other expectations, and to identify and realize additional business opportunities, including

More news about: Ginkgo Bioworks


Nov 18, 2025, 07:30 ET Metavesco Quarterly Net Income Soars to $1.78 Million on Crypto Gains

its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; and (iii) growth strategy and operating strategy. The words "may", "would", "will", "expect", "estimate", "can", "believe", "potential", and similar expressions

More news about: Metavesco, Inc.


Nov 18, 2025, 07:09 ET Blockchain for Good Alliance (BGA) Berikan Penghargaan untuk Proyek Blockchain Penuh Terobosan yang Mempercepat Pencapaian TPB dalam Sebuah Forum yang Digelar Tahun Ini

($3.000) Growth Stage: Token Tails (Juara I – $30.000); Rumsan (Juara II – $20.000); EsusFarm (Juara III – $10.000); Joint Funds Initiatives

More news about: Blockchain for Good Alliance (BGA)


Nov 18, 2025, 07:03 ET Monogram Capital Partners Closes Oversubscribed $350 Million Fund III

private equity firm focused on building the next generation of enduring consumer businesses, has closed its third fund, Monogram Capital Partners Fund III, at its $350 million hard cap. The fund was substantially oversubscribed, reflecting strong demand from both returning and new investors and bringing

More news about: Monogram Capital Partners


Nov 18, 2025, 07:00 ET Armata Pharmaceuticals Announces Key Opinion Leader Webinar on S. aureus Bacteremia and AP-SA02 Hosted by Jones Research on November 25th at 10:00am EST

defined as one week following the end of IV treatment with AP-SA02 (day 12), (ii) TOC for BAT, defined as one week following the end of IV BAT, and (iii) end of study ("EOS"), defined as four weeks following the end of IV BAT. AP-SA02 combined with BAT had

More news about: Armata Pharmaceuticals, Inc.


Nov 18, 2025, 06:00 ET Hyperscale Data Bitcoin Treasury At Approximately $72.5 Million Representing Approximately 94% of Market Capitalization

"The recent price volatility of Bitcoin has only served to validate our disciplined approach," stated Milton "Todd" Ault III, Executive Chairman of Hyperscale Data. "Our commitment to dollar-cost averaging for our Bitcoin treasury strategy isn't reactive, it is

More news about: Hyperscale Data Inc.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.